Maeva Lefebvre

Angers, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 28, 2026

Clinical characteristics and treatments of imported loiasis patients with microfilaraemia diagnosed in France, 2000-2022.

Clinical characteristics and treatments of imported loiasis patients with microfilaraemia diagnosed in France, 2000-2022.

Journal: Travel medicine and infectious disease
Published: January 12, 2026

Ancestral Wuhan SARS-CoV-2 anti-spike CD4+ T cells predict protection from symptomatic omicron breakthrough infection.

Ancestral Wuhan SARS-CoV-2 anti-spike CD4+ T cells predict protection from symptomatic omicron breakthrough infection.

Journal: Vaccine
Published: January 03, 2026

Toward a simplified vaccination schedule in France: How can the tools we possess be put to better use?

Toward a simplified vaccination schedule in France: How can the tools we possess be put to better use?

Journal: Infectious diseases now
Published: November 05, 2025

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.

Journal: JAMA network open
Published: April 23, 2024

Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination.

Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination.

Journal: iScience
Published: April 08, 2024

Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPART.

Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPART.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 08, 2024

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.

Journal: Infectious diseases now
Published: October 13, 2023

Measles in vulnerable populations: An outbreak in Roma settlements of Loire-Atlantique, France, 2019.

Measles in vulnerable populations: An outbreak in Roma settlements of Loire-Atlantique, France, 2019.

Journal: Journal of medical virology
Published: September 23, 2023

Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries.

Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries.

Journal: Journal of clinical medicine
Published: March 29, 2023

Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).

Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: September 27, 2022

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.

Journal: Scientific reports
Published: June 02, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026